These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 6299864)

  • 1. The ontogeny of delta-9-tetrahydrocannabinol responsiveness in the rabbit.
    Fish BS; Consroe P
    Dev Psychobiol; 1983 Mar; 16(2):147-58. PubMed ID: 6299864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inheritance of delta 9-tetrahydrocannabinol seizure susceptibility in rabbits.
    Fish BS; Consroe P; Fox RR
    J Hered; 1981; 72(3):215-6. PubMed ID: 6268703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.
    Hart CL; Ward AS; Haney M; Comer SD; Foltin RW; Fischman MW
    Psychopharmacology (Berl); 2002 Dec; 164(4):407-15. PubMed ID: 12457271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic mapping of the time-dependent effects of delta 9-tetrahydrocannabinol administration in the rat.
    Whitlow CT; Freedland CS; Porrino LJ
    Psychopharmacology (Berl); 2002 May; 161(2):129-36. PubMed ID: 11981592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine.
    Cadoni C; Pisanu A; Solinas M; Acquas E; Di Chiara G
    Psychopharmacology (Berl); 2001 Nov; 158(3):259-66. PubMed ID: 11713615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabbit behavioral model of marijuana psychoactivity in humans.
    Consroe P; Fish BS
    Med Hypotheses; 1981 Aug; 7(8):1079-90. PubMed ID: 6270517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual administration of Delta9-tetrahydrocannabinol/beta-cyclodextrin complex increases the bioavailability of Delta9-tetrahydrocannabinol in rabbits.
    Mannila J; Järvinen T; Järvinen K; Tervonen J; Jarho P
    Life Sci; 2006 Mar; 78(17):1911-4. PubMed ID: 16266727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic treatment with Delta(9)-tetrahydrocannabinol impairs spatial memory and reduces zif268 expression in the mouse forebrain.
    Boucher AA; Vivier L; Metna-Laurent M; Brayda-Bruno L; Mons N; Arnold JC; Micheau J
    Behav Pharmacol; 2009 Feb; 20(1):45-55. PubMed ID: 19179850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
    Müller-Vahl KR; Schneider U; Koblenz A; Jöbges M; Kolbe H; Daldrup T; Emrich HM
    Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids. I. Behavioral effects.
    Stark P; Dews PB
    J Pharmacol Exp Ther; 1980 Jul; 214(1):124-30. PubMed ID: 6771386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission.
    Cadoni C; Valentini V; Di Chiara G
    J Neurochem; 2008 Aug; 106(4):1586-93. PubMed ID: 18513369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.
    D'Souza DC; Abi-Saab WM; Madonick S; Forselius-Bielen K; Doersch A; Braley G; Gueorguieva R; Cooper TB; Krystal JH
    Biol Psychiatry; 2005 Mar; 57(6):594-608. PubMed ID: 15780846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic treatment with Delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats.
    Kolb B; Gorny G; Limebeer CL; Parker LA
    Synapse; 2006 Nov; 60(6):429-36. PubMed ID: 16881072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of RM-beta-CD on sublingual bioavailability of Delta9-tetrahydrocannabinol in rabbits.
    Mannila J; Järvinen T; Järvinen K; Tarvainen M; Jarho P
    Eur J Pharm Sci; 2005 Sep; 26(1):71-7. PubMed ID: 15955678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose and behavioral context dependent inhibition of movement and basal ganglia neural activity by Delta-9-tetrahydrocannabinol during spontaneous and treadmill locomotion tasks in rats.
    Shi LH; Luo F; Woodward DJ; Chang JY
    Synapse; 2005 Jan; 55(1):1-16. PubMed ID: 15499609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity.
    Singh ME; McGregor IS; Mallet PE
    Neuropharmacology; 2005 Dec; 49(8):1189-200. PubMed ID: 16137723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
    Rog DJ; Nurmikko TJ; Young CA
    Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.
    Curran HV; Brignell C; Fletcher S; Middleton P; Henry J
    Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.